glp-1 and gip/glp-1 receptor agonists GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica GIP and GLP‐1, the two
Description
Individual results vary
Discover how GLP-1 agonists help improve cardiovascular outcomes independently of glucose control.
Newly released clinical trial data on the GLP-1 agonist drug Wegovy found that weight loss was sustained for up to four years after participants started taking the once-weekly injected medication
Liraglutide offers an affordable GLP-1 option for managing antipsychotic weight gain.
